1. Stocks
    2. /
  2. Mesoblast Limited (ASX: MSB)
    3. /

Mesoblast Limited (ASX: MSB) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Mesoblast Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Mesoblast Limited (ASX: MSB)
    Latest News

    A man wearing glasses sits back in his desk chair with his hands behind his head staring smiling at his computer screens as the ASX share prices keep rising
    Best Shares

    Did you own the 5 best ASX All Ordinaries shares of 2024?

    | Bronwyn Allen

    The ASX All Ords Index slightly outperformed the benchmark ASX 200 in 2024.

    Read more »

    Three happy office workers cheer as they read about good financial news on a laptop.
    Share Gainers

    Why DroneShield, Invictus Energy, Mesoblast, Weebit Nano shares are rising today

    | James Mickleboro

    These shares are on course to end the year on a positive note. But why?

    Read more »

    Emotional euphoric young woman giving high five to male partner, celebrating family achievement, getting bank loan approval, or financial or investing success.
    Share Gainers

    Why Bowen Coal, Droneshield, Mesoblast, and St Barbara shares are racing higher today

    | James Mickleboro

    These shares are ending the week positively. But why?

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher

    | James Mickleboro

    These shares are having a better day than most today. But why?

    Read more »

    Shares vs property concept illustrated by graphs in the background and house models on coins.
    Share Market News

    Shares vs. property: Biggest investment trends of 2024

    | Bronwyn Allen

    As another year of investing draws to a close, we review the most significant trends.

    Read more »

    A woman with short brown hair and wearing a yellow top looks at the camera with a puzzled and shocked look on her face as the Westpac share price goes down for no reason today
    Share Fallers

    Why Bellevue Gold, Mesoblast, Pilbara Minerals, and Wesfarmers shares are dropping today

    | James Mickleboro

    These shares are ending the week deep in the red. What's going on?

    Read more »

    Shot of a scientist using a computer while conducting research in a laboratory.
    Healthcare Shares

    Why the Mesoblast share price is diving 18% after an FDA win

    | Bernd Struben

    Investors are sending the Mesoblast share price tumbling on Friday. But why?

    Read more »

    A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
    52-Week Highs

    3 ASX 300 shares smashing new highs while the market dives

    | Sebastian Bowen

    These three shares are running hot amid a market meltdown.

    Read more »

    Man pointing an upward line on a bar graph symbolising a rising share price.
    Share Gainers

    Why Champion Iron, EBR Systems, Mesoblast, and Patriot Battery Metals shares are surging today

    | James Mickleboro

    These shares are avoiding the market selloff on Thursday. But why?

    Read more »

    A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
    Healthcare Shares

    Mesoblast share price rockets 30% on big US FDA news

    | James Mickleboro

    Big news is giving this biotech a huge lift on Thursday.

    Read more »

    Doctor doing a telemedicine using laptop at a medical clinic
    Healthcare Shares

    If you'd invested $5,000 in this ASX 300 healthcare stock a year ago, you'd now have $30,000!

    | Sebastian Bowen

    This stock has made millions for investors over just a few months.

    Read more »

    A man looks down with fright as he falls towards the ground.
    Share Fallers

    Why 29Metals, Guzman Y Gomez, Mesoblast, and Pilbara Minerals shares are falling today

    | James Mickleboro

    These shares are having a tough time on Thursday. What's going on?

    Read more »

    Frequently Asked Questions

    No, Mesoblast does not pay shareholder dividends at this time.

    Yes, Mesoblast is listed on the ASX and the US Nasdaq under the ticker code NASDAQ: MESO.

    Mesoblast Ltd listed on the ASX on 16 December 2004.

    MSB ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Mesoblast Limited

    Mesoblast Ltd (ASX: MSB) is a clinical-stage biotechnology company. It develops and commercialises allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care.

    Its portfolio of Phase 3 product candidates includes its flagship remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD) as well as moderate to severe acute respiratory distress syndrome (ARDS). Its other candidates include REVASCOR® for advanced chronic heart failure and MPC-06-ID for chronic low back pain due to degenerative disc disease. These cell therapy candidates are towards the latter stages of their clinical trial pipelines. 

    Mesoblast has locations in Australia, the United States, and Singapore and is dual-listed on the ASX and the US Nasdaq (NASDAQ: MESO).

    Profile

    since

    Note